论文部分内容阅读
目的:讨论雾化吸入沐舒坦治疗新生儿肺炎的临床效果。方法:选取新生儿肺炎的患儿采用沐舒坦进行祛痰治疗。随机分为观察组和对照组,对照组患儿采用静脉滴注给药,观察组患儿采用雾化吸入给药。结果:观察组患儿的治疗有效率为97.7%,对照组为93.0%(P<0.01)。同时观察组患儿的啰音消失时间以及治疗时间等均要少于观察组患儿(P<0.01)。结论:沐舒坦的雾化吸入给药能有效的减少患儿的痰液,保持呼吸道的通畅,改善患儿的临床症状,能取得满意的临床效果。
Objective: To discuss the clinical effect of inhalation of mucosolvan in the treatment of neonatal pneumonia. Methods: Children with neonatal pneumonia were treated with mucosolvan for expectorant treatment. Randomly divided into observation group and control group, the control group of children given intravenous drip, the observation group of children with inhaled medication. Results: The effective rate of treatment group was 97.7% in the observation group and 93.0% in the control group (P <0.01). At the same time the observation group patients with rales disappear time and treatment time were less than the observation group children (P <0.01). CONCLUSIONS: Mucosolvan inhalation can effectively reduce sputum in children, keep the airway open and improve the clinical symptoms of children, and achieve satisfactory clinical results.